HomeCompareATMS vs DGRO

ATMS vs DGRO: Dividend Comparison 2026

ATMS yields 401.61% · DGRO yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATMS wins by $11778.58M in total portfolio value
10 years
ATMS
ATMS
● Live price
401.61%
Share price
$0.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11778.61M
Annual income
$7,906,058,517.03
Full ATMS calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.13%
Share price
$68.98
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$239.96
Full DGRO calculator →

Portfolio growth — ATMS vs DGRO

📍 ATMS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATMSDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATMS + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATMS pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATMS
Annual income on $10K today (after 15% tax)
$34,136.55/yr
After 10yr DRIP, annual income (after tax)
$6,720,149,739.48/yr
DGRO
Annual income on $10K today (after 15% tax)
$181.24/yr
After 10yr DRIP, annual income (after tax)
$203.97/yr
At 15% tax rate, ATMS beats the other by $6,720,149,535.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATMS + DGRO for your $10,000?

ATMS: 50%DGRO: 50%
100% DGRO50/50100% ATMS
Portfolio after 10yr
$5889.32M
Annual income
$3,953,029,378.50/yr
Blended yield
67.12%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATMS buys
0
DGRO buys
0
No recent congressional trades found for ATMS or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATMSDGRO
Forward yield401.61%2.13%
Annual dividend / share$2.00$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$11778.61M$31.6K
Annual income after 10y$7,906,058,517.03$239.96
Total dividends collected$11422.67M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ATMS vs DGRO ($10,000, DRIP)

YearATMS PortfolioATMS Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$50,861$40,160.64$11,293$213.22+$39.6KATMS
2$245,318$190,896.83$12,730$217.32+$232.6KATMS
3$1,123,012$860,522.07$14,326$221.10+$1.11MATMS
4$4,883,199$3,681,575.64$16,098$224.56+$4.87MATMS
5$20,186,343$14,961,320.35$18,064$227.74+$20.17MATMS
6$79,400,927$57,801,539.78$20,246$230.65+$79.38MATMS
7$297,441,682$212,482,690.61$22,666$233.30+$297.42MATMS
8$1,062,165,133$743,902,532.93$25,349$235.73+$1062.14MATMS
9$3,619,206,563$2,482,689,870.56$28,325$237.94+$3619.18MATMS
10$11,778,609,539$7,906,058,517.03$31,624$239.96+$11778.58MATMS

ATMS vs DGRO: Complete Analysis 2026

ATMSStock

Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.

Full ATMS Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this ATMS vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATMS vs SCHDATMS vs JEPIATMS vs OATMS vs KOATMS vs MAINATMS vs VIGATMS vs NOBLATMS vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.